medcart
Delivery Pincode
Enter Pincode
View Cart
Login | Signup
Coxbact 3 150mg/500mg/225mg Tablet
Share
medicinePrescription Required.Why?
Marketer
Alpic Remedies Ltd
Composition
Isoniazid (Inh) (150mg) + Pyrazinamide (500mg) + Rifampicin (225mg)
100% Genuine Products
Safe & Secure Payment
Contact Less Delivery
Fully Sanitized Packing
About Coxbact 3 150mg/500mg/225mg Tablet
This medication is a combination of three antibiotics used primarily to treat tuberculosis. It's crucial to follow your doctor's prescribed dosage and duration strictly. Report any side effects, especially liver or kidney-related symptoms, to your doctor immediately. Alcohol should be avoided. This is not a standalone cure; this drug regimen is typically part of a broader treatment plan.
Ingredients of Coxbact 3 150mg/500mg/225mg Tablet

    Isoniazid

    An antibiotic that targets the bacteria that cause tuberculosis.

    Pyrazinamide

    Another antibiotic effective against tuberculosis bacteria.

    Rifampicin

    A broad-spectrum antibiotic also used in treating tuberculosis and other bacterial infections.

Direction for Use of Coxbact 3 150mg/500mg/225mg Tablet

    Treatment of tuberculosis (TB), specifically pulmonary TB and other forms of TB disease.

    Part of a multidrug regimen to combat drug-resistant TB strains (in consultation with a physician).

How Coxbact 3 150mg/500mg/225mg Tablet Works

The three drugs work synergistically. Isoniazid inhibits the synthesis of mycolic acids, essential components of the mycobacterial cell wall. Pyrazinamide's mechanism isn't fully understood, but it's believed to interfere with bacterial metabolism. Rifampicin inhibits bacterial DNA-dependent RNA polymerase, thus blocking bacterial RNA synthesis.

Storage and Handling of Coxbact 3 150mg/500mg/225mg Tablet

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children. Always follow the specific storage instructions provided by your pharmacist.

Dosage of Coxbact 3 150mg/500mg/225mg Tablet

    Dosage is determined by a physician based on individual factors (age, weight, liver/kidney function).

    Usually taken once daily, but the regimen can vary.

    Precisely follow the prescribed dose, frequency, and duration of treatment; do not discontinue the medication without consulting your doctor.

    Should be taken with food to minimize stomach upset.

Side effects of Coxbact 3 150mg/500mg/225mg Tablet

Jaundice (yellowing of skin and eyes - indication of liver damage)

    Nausea, vomiting, diarrhea

    Loss of appetite

    Fatigue

    Headache

    Dizziness

    Druginduced hepatitis (liver inflammation)

    Allergic reactions (rash, itching, swelling)

    Dark urine or lightcolored stools.

Safety Consideration or Warnings
    Alcohol Consumption

    Alcohol consumption is strongly discouraged while taking this medication, as it can increase the risk of liver damage.

    While Driving or operating Machinery

    May cause dizziness or drowsiness; avoid driving or operating machinery if affected.

    Pregnant & Breastfeeding Women

    Inform your doctor if you are pregnant, breastfeeding, or planning to become pregnant. This medication can pass into breast milk and may have harmful effects on the infant.

    Children

    Dosage adjustments are necessary for children. Follow your physician's instructions.

    Kidney

    Kidney function should be monitored, especially in patients with pre-existing kidney disease. Dose adjustments may be needed.

    Liver

    Liver function tests are usually recommended before and during treatment due to the potential for liver damage.

References

    Consult your physician or pharmacist for comprehensive details and specific references.

    Refer to the patient information leaflet provided with your medication.

Last Updated On 12 Aug. 2025 | 09:02 PM (IST)
Report Error
Was this Product Information helpful?
Some people found this information helpful
User Feedback
Disclaimer
We, at MedCart make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers.